CODX vs CPRT · rev $3.9M vs P/E 19, $28.66B cap
Co-Diagnostics, Inc. Common Stock (CODX) versus Copart Inc (CPRT) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Copart Inc (CPRT) is a specialty business services company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
CPRT does not have a complete income-statement cache yet.
CODX currently screens at market cap $31.4M. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
Not investment advice. Open the CODX and CPRT stock pages for the full models.
Not investment advice.